USA Bachem Pharma is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, and Lipid Nanoparticles (LNPs). With a team of scientific experts, cutting-edge technology, and a global network of fully integrated services, the Tirzepatide Firm delivers bespoke solutions spanning the entire drug lifecycle of liraglutide, tirzepatide injections, semaglutide injections and GLP-1 Peptides.
USA Bachem Pharma ensures a dependable supply of generic peptides with a specialty in Tirzepatide, Semaglutide, and other GLP-1 peptides in bulk grams to kilograms. By leveraging the combined expertise of teams within our globally-integrated cGMP facility network, we offer tailored services for:
Glucagon
Retatrutide
GLP-1 Solids
We are an FDA-approved manufacturer of Tirzepatide and Semaglutide API; we specialize in cutting-edge peptides, including Retatrutide, Cagrillintide, and others. Our commitment to innovation ensures that we deliver high-quality API peptides for both research and clinical development in forms such as capsules, tablets, liquid injectables, and syrups. We are a global provider of peptides for research, clinical development, and commercial applications.
USA Bachem Pharma is your CDMO partner for reliable, compliant, and innovative pharmaceutical manufacturing of NAD and peptides that helps humans be at their optimum health and balance. With decades of experience in peptides and injectable solutions, we bring together deep expertise and advanced infrastructure to support every stage of your drug’s development.
We have the top outsourced facility for major Tirzepatide, Semaglutide, Liraglutide, and Dulaglutide brands manufacturing and packaging, enabling pharmaceutical industries to keep up with the high demand of GLP-1 peptide products.
Our network of facilities spans Switzerland, North America, Africa, and Europe, allowing us to offer flexible, efficient, and secure global support for every project scale and timeline.
USA Bachem Pharma is a global leader in pioneering the manufacture of lipid-based products for pharmaceutical
development. We offer custom and standard synthetic lipids used in mRNA, siRNA, and DNA delivery.
No matter the scale or phase of development, we can support you in developing groundbreaking medicines with both
custom and standard synthetic lipids.
USA Bachem Pharm is a leading, innovation-driven company specializing in the development and manufacture of
peptides and oligonucleotides.
The company, with over 50 years of experience and expertise, provides products for research, clinical
development, and commercial application to pharmaceutical and biotechnology companies worldwide, offering a
comprehensive range of services.
We provide formulation, filling, and packaging of sterile injectables using cutting-edge technology in aseptic environments.
With a strong analytical infrastructure, we ensure every product meets strict regulatory guidelines through every phase of development.
USA Bachem Pharma is a global leader in pioneering the manufacture of GLP-1 peptides in solid, liquid, and
powder formats for pharmaceutical development.
No matter the scale or phase of development, we can support you in developing groundbreaking medicines with both
custom and standard synthetic lipids.
Our high-quality peptide synthesis and API capabilities ensure safety, consistency, and scalability for peptide
solid form dosages and highly potent compounds.
Other delivery forms, such as capsules, tablets, and customized forms for clinical research and development, are
available.
We provide formulation, filling, and packaging of sterile injectables using cutting-edge technology in aseptic environments.
With a strong analytical infrastructure, USA Bachem ensures every product meets strict regulatory guidelines through every phase of development.